{"entity":{"type":"insider","cik":"0001829252","url":"/insider/0001829252","json_url":"/insider/0001829252.json","name":"Garg Pushkal","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":180,"n_filings":20,"first":"2023-03-07","last":"2026-03-06","span_basis":"filed_date"},"name_variants":[{"name":"Garg Pushkal","source":"filing","n_filings":20,"first_seen":"2023-03-07","last_seen":"2026-03-06"}],"transactions":[{"id":6158724,"accession":"0001735276-26-000063","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001735276-26-000063","line_url":"/filing/0001735276-26-000063","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2404.0,"shares_display":"2,404","price_per_share":323.9649417637271,"price_display":"323.96","price_state":"stated","total_value":778811.72,"total_display":"778,811.72","total_whole":"778,812","shares_owned_after":19703.0,"shares_owned_after_display":"19,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-06","scope":"insider","n_lines":4},{"id":6158712,"accession":"0001735276-26-000063","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-26-000063","line_url":"/filing/0001735276-26-000063","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2309.0,"shares_display":"2,309","price_per_share":323.0765829363361,"price_display":"323.08","price_state":"stated","total_value":745983.83,"total_display":"745,983.83","total_whole":"745,984","shares_owned_after":21577.0,"shares_owned_after_display":"21,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider","n_lines":8},{"id":6140545,"accession":"0001735276-26-000052","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001735276-26-000052","line_url":"/filing/0001735276-26-000052","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1775.0,"shares_display":"1,775","price_per_share":319.74446197183096,"price_display":"319.74","price_state":"stated","total_value":567546.42,"total_display":"567,546.42","total_whole":"567,546","shares_owned_after":23869.0,"shares_owned_after_display":"23,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-04","scope":"insider","n_lines":4},{"id":6140533,"accession":"0001735276-26-000052","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001735276-26-000052","line_url":"/filing/0001735276-26-000052","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1717.0,"shares_display":"1,717","price_per_share":327.6558124635993,"price_display":"327.66","price_state":"stated","total_value":562585.03,"total_display":"562,585.03","total_whole":"562,585","shares_owned_after":26053.0,"shares_owned_after_display":"26,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider","n_lines":10},{"id":5849248,"accession":"0001735276-26-000038","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-26-000038","line_url":"/filing/0001735276-26-000038","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4627.0,"shares_display":"4,627","price_per_share":331.3377090987681,"price_display":"331.34","price_state":"stated","total_value":1533099.58,"total_display":"1,533,099.58","total_whole":"1,533,100","shares_owned_after":24370.0,"shares_owned_after_display":"24,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-02","scope":"insider","n_lines":5},{"id":6003963,"accession":"0001735276-26-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-26-000029","line_url":"/filing/0001735276-26-000029#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2242.0,"shares_display":"2,242","price_per_share":310.0808,"price_display":"310.08","price_state":"stated","total_value":695201.1536,"total_display":"695,201.15","total_whole":"695,201","shares_owned_after":24848.0,"shares_owned_after_display":"24,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-17","scope":"insider"},{"id":5949328,"accession":"0001735276-26-000015","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-22","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":220.0,"shares_display":"220","price_per_share":365.56,"price_display":"365.56","price_state":"stated","total_value":80423.2,"total_display":"80,423.20","total_whole":"80,423","shares_owned_after":22803.0,"shares_owned_after_display":"22,803","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949325,"accession":"0001735276-26-000015","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-21","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":199.0,"shares_display":"199","price_per_share":364.83,"price_display":"364.83","price_state":"stated","total_value":72601.17,"total_display":"72,601.17","total_whole":"72,601","shares_owned_after":23023.0,"shares_owned_after_display":"23,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949324,"accession":"0001735276-26-000015","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-20","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155.0,"shares_display":"155","price_per_share":360.22,"price_display":"360.22","price_state":"stated","total_value":55834.1,"total_display":"55,834.10","total_whole":"55,834","shares_owned_after":23440.0,"shares_owned_after_display":"23,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949323,"accession":"0001735276-26-000015","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-19","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":123.0,"shares_display":"123","price_per_share":358.18,"price_display":"358.18","price_state":"stated","total_value":44056.14,"total_display":"44,056.14","total_whole":"44,056","shares_owned_after":23680.0,"shares_owned_after_display":"23,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949321,"accession":"0001735276-26-000015","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-18","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98.0,"shares_display":"98","price_per_share":361.45,"price_display":"361.45","price_state":"stated","total_value":35422.1,"total_display":"35,422.10","total_whole":"35,422","shares_owned_after":23342.0,"shares_owned_after_display":"23,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949319,"accession":"0001735276-26-000015","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-17","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":96.0,"shares_display":"96","price_per_share":357.17,"price_display":"357.17","price_state":"stated","total_value":34288.32,"total_display":"34,288.32","total_whole":"34,288","shares_owned_after":23803.0,"shares_owned_after_display":"23,803","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949316,"accession":"0001735276-26-000015","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-16","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92.0,"shares_display":"92","price_per_share":368.62,"price_display":"368.62","price_state":"stated","total_value":33913.04,"total_display":"33,913.04","total_whole":"33,913","shares_owned_after":22620.0,"shares_owned_after_display":"22,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949314,"accession":"0001735276-26-000015","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-15","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85.0,"shares_display":"85","price_per_share":359.14,"price_display":"359.14","price_state":"stated","total_value":30526.9,"total_display":"30,526.90","total_whole":"30,527","shares_owned_after":23595.0,"shares_owned_after_display":"23,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949312,"accession":"0001735276-26-000015","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-14","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73.0,"shares_display":"73","price_per_share":362.38,"price_display":"362.38","price_state":"stated","total_value":26453.74,"total_display":"26,453.74","total_whole":"26,454","shares_owned_after":23269.0,"shares_owned_after_display":"23,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949311,"accession":"0001735276-26-000015","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-13","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50.0,"shares_display":"50","price_per_share":366.41,"price_display":"366.41","price_state":"stated","total_value":18320.5,"total_display":"18,320.50","total_whole":"18,321","shares_owned_after":22753.0,"shares_owned_after_display":"22,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949310,"accession":"0001735276-26-000015","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-12","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47.0,"shares_display":"47","price_per_share":363.55,"price_display":"363.55","price_state":"stated","total_value":17086.85,"total_display":"17,086.85","total_whole":"17,087","shares_owned_after":23222.0,"shares_owned_after_display":"23,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949309,"accession":"0001735276-26-000015","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-11","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42.0,"shares_display":"42","price_per_share":355.16,"price_display":"355.16","price_state":"stated","total_value":14916.72,"total_display":"14,916.72","total_whole":"14,917","shares_owned_after":23940.0,"shares_owned_after_display":"23,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949308,"accession":"0001735276-26-000015","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-10","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41.0,"shares_display":"41","price_per_share":367.4,"price_display":"367.40","price_state":"stated","total_value":15063.4,"total_display":"15,063.40","total_whole":"15,063","shares_owned_after":22712.0,"shares_owned_after_display":"22,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949306,"accession":"0001735276-26-000015","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-9","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41.0,"shares_display":"41","price_per_share":356.09,"price_display":"356.09","price_state":"stated","total_value":14599.69,"total_display":"14,599.69","total_whole":"14,600","shares_owned_after":23899.0,"shares_owned_after_display":"23,899","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949305,"accession":"0001735276-26-000015","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40.0,"shares_display":"40","price_per_share":369.48,"price_display":"369.48","price_state":"stated","total_value":14779.2,"total_display":"14,779.20","total_whole":"14,779","shares_owned_after":22580.0,"shares_owned_after_display":"22,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949304,"accession":"0001735276-26-000015","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-7","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39.0,"shares_display":"39","price_per_share":353.95,"price_display":"353.95","price_state":"stated","total_value":13804.05,"total_display":"13,804.05","total_whole":"13,804","shares_owned_after":23982.0,"shares_owned_after_display":"23,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949302,"accession":"0001735276-26-000015","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19.0,"shares_display":"19","price_per_share":375.65,"price_display":"375.65","price_state":"stated","total_value":7137.35,"total_display":"7,137.35","total_whole":"7,137","shares_owned_after":22526.0,"shares_owned_after_display":"22,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5949300,"accession":"0001735276-26-000015","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-26-000015","line_url":"/filing/0001735276-26-000015#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001829252","owner_name":"Garg Pushkal","owner_display_name":"Garg Pushkal","owner_url":"/insider/0001829252","role":"Officer (EVP Chief R&D)","role_mark":"O","role_mark_label":"Officer (EVP Chief R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Chief R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18.0,"shares_display":"18","price_per_share":370.87,"price_display":"370.87","price_state":"stated","total_value":6675.66,"total_display":"6,675.66","total_whole":"6,676","shares_owned_after":22562.0,"shares_owned_after_display":"22,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"}],"collapsed":true,"next_cursor":"2026-01-12|5949300","ledger_fault":false,"count":{"value":180,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":180,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":180},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Officer (EVP Chief R&D)","n_filings":20,"first_seen":"2023-03-07","last_seen":"2026-03-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001829252","retrieved_at":"2026-08-27T09:48:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}